ATE457779T1 - Metallorganische komplexe auf manganbasis, pharmazeutische zusammensetzungen und diätetische produkte - Google Patents
Metallorganische komplexe auf manganbasis, pharmazeutische zusammensetzungen und diätetische produkteInfo
- Publication number
- ATE457779T1 ATE457779T1 AT04715267T AT04715267T ATE457779T1 AT E457779 T1 ATE457779 T1 AT E457779T1 AT 04715267 T AT04715267 T AT 04715267T AT 04715267 T AT04715267 T AT 04715267T AT E457779 T1 ATE457779 T1 AT E457779T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- manganeous
- compounds
- dietary products
- organometal complexes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03290491A EP1452175A1 (de) | 2003-02-28 | 2003-02-28 | Organometallische Komplexe entahltend Mangan, pharmazeutische Formulierungen und Diätetika |
PCT/EP2004/001961 WO2004075990A1 (en) | 2003-02-28 | 2004-02-27 | Manganese based organometallic complexes, pharmaceutical compositions and dietetic products |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE457779T1 true ATE457779T1 (de) | 2010-03-15 |
Family
ID=32748999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04715267T ATE457779T1 (de) | 2003-02-28 | 2004-02-27 | Metallorganische komplexe auf manganbasis, pharmazeutische zusammensetzungen und diätetische produkte |
Country Status (8)
Country | Link |
---|---|
US (2) | US20060128678A1 (de) |
EP (2) | EP1452175A1 (de) |
JP (1) | JP2006520752A (de) |
AT (1) | ATE457779T1 (de) |
AU (1) | AU2004216473B2 (de) |
CA (1) | CA2517370C (de) |
DE (1) | DE602004025557D1 (de) |
WO (1) | WO2004075990A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1452175A1 (de) * | 2003-02-28 | 2004-09-01 | Medesis Pharma S.A. | Organometallische Komplexe entahltend Mangan, pharmazeutische Formulierungen und Diätetika |
EP1652512A1 (de) * | 2004-11-02 | 2006-05-03 | Medesis Pharma | Umkehrmizellen-Zusammensetzung zur Verabreichung von Metallkationen enthaltend einen Diglycerid und einen Phytosterol und Verfahren zur Herstellung |
DK2550020T3 (en) | 2010-03-24 | 2015-10-05 | Medesis Pharma | REVERSE MICELLE MICROEMULSION, INCLUDING METAL IONS AND USES THEREOF |
US10155783B2 (en) | 2013-05-28 | 2018-12-18 | Merck Patent Gmbh | Manganese complexes and use thereof for preparing thin films |
JP6113133B2 (ja) | 2014-11-06 | 2017-04-12 | 日本メナード化粧品株式会社 | 幹細胞の未分化状態維持剤及び増殖促進剤 |
CN112691120B (zh) * | 2019-10-23 | 2022-03-29 | 北京大学 | 二价锰在制备免疫增强药物或抗肿瘤药物中的应用 |
CN113061259B (zh) * | 2021-03-14 | 2022-03-29 | 华中科技大学同济医学院附属协和医院 | 用于缺血性脑卒中治疗的金属有机框架材料的制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0587055B1 (de) * | 1992-09-09 | 2001-12-05 | Bio-Technology General Corporation | Verwendung von Mangan-Superoxiddismutase (Mn-SOD) zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen in niedriger Dosierung |
JPH07126176A (ja) * | 1993-06-15 | 1995-05-16 | Hiroshi Sakurai | 活性酸素抑制剤 |
FR2729957B1 (fr) * | 1995-01-31 | 1997-12-05 | Maurel Sante | Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant. |
FR2750606B1 (fr) * | 1996-07-03 | 1999-01-29 | Maurel Sante | Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant |
US5715143A (en) * | 1996-07-22 | 1998-02-03 | Delco Electronics Corporation | Carrier system for integrated circuit carrier assemblies |
DK1616869T3 (da) * | 1999-01-25 | 2012-05-07 | Nat Jewish Health | Substituerede porphyriner og deres terapeutiske anvendelse |
JP2000247978A (ja) * | 1999-02-25 | 2000-09-12 | Toyo Ink Mfg Co Ltd | 金属ポルフィリン錯体及びそれを含有してなる医薬組成物 |
GB2368521B (en) * | 2000-10-31 | 2004-12-08 | Jasali Ltd | Pharmaceutical or dietary composition containing a vegetable oil in particular olive oil and sitosterol |
AU2002312194B8 (en) * | 2001-06-01 | 2008-05-15 | Aeolus Sciences, Inc. | Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance |
EP1452175A1 (de) * | 2003-02-28 | 2004-09-01 | Medesis Pharma S.A. | Organometallische Komplexe entahltend Mangan, pharmazeutische Formulierungen und Diätetika |
-
2003
- 2003-02-28 EP EP03290491A patent/EP1452175A1/de not_active Withdrawn
-
2004
- 2004-02-27 DE DE602004025557T patent/DE602004025557D1/de not_active Expired - Lifetime
- 2004-02-27 JP JP2006501967A patent/JP2006520752A/ja active Pending
- 2004-02-27 US US10/546,155 patent/US20060128678A1/en not_active Abandoned
- 2004-02-27 WO PCT/EP2004/001961 patent/WO2004075990A1/en active Application Filing
- 2004-02-27 EP EP04715267A patent/EP1606021B1/de not_active Expired - Lifetime
- 2004-02-27 AT AT04715267T patent/ATE457779T1/de not_active IP Right Cessation
- 2004-02-27 CA CA2517370A patent/CA2517370C/en not_active Expired - Fee Related
- 2004-02-27 AU AU2004216473A patent/AU2004216473B2/en not_active Ceased
-
2009
- 2009-05-04 US US12/434,848 patent/US20090247492A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1452175A1 (de) | 2004-09-01 |
AU2004216473B2 (en) | 2009-05-07 |
EP1606021A1 (de) | 2005-12-21 |
DE602004025557D1 (de) | 2010-04-01 |
WO2004075990A1 (en) | 2004-09-10 |
EP1606021B1 (de) | 2010-02-17 |
US20060128678A1 (en) | 2006-06-15 |
CA2517370C (en) | 2012-02-07 |
CA2517370A1 (en) | 2004-09-10 |
JP2006520752A (ja) | 2006-09-14 |
US20090247492A1 (en) | 2009-10-01 |
AU2004216473A1 (en) | 2004-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GEP20084420B (en) | Use of imidazole compounds for the treatment of neurodegenerative disorders | |
ATE417607T1 (de) | Sphingolipide gegen krankhafte prozesse in lipid rafts | |
MX2010004074A (es) | Combinacion 059. | |
CY1110353T1 (el) | Ανοσορρυθμιστικοι ολιγοσακχαριτες | |
WO2005116088A3 (en) | Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells | |
WO2006001877A3 (en) | Combination treatment for neurodegenerative disorders comprising r-flurbiprofen | |
NO20053855D0 (no) | 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer. | |
ATE345130T1 (de) | Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen | |
MY145077A (en) | Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
NO20062767L (no) | Immunoglobuliner | |
NO20050807L (no) | Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser | |
MX337100B (es) | Compuestos alcoxi para el tratamiento de enfermedades. | |
WO2007112403A3 (en) | Prevention and treatment of ischemia-reperfusion injury | |
TW200628473A (en) | Novel heterocycles | |
ATE456955T1 (de) | Verwendung von cyclodextrin zur behandlung und vorbeugung von entzündlichen bronchialerkrankungen | |
ECSP066986A (es) | Beta-carbolinas utiles para tratar enfermedades inflamatorias | |
WO2005074887A3 (en) | Amphiphilic star-like or scorpion-like macromolecules, various compositions and uses thereof | |
BR112022018645A2 (pt) | Composições e métodos para tratar ou prevenir doenças inflamatórias, incluindo diabetes mellitus tipo i e tipo ii e doenças da tireoide | |
WO2008013986A3 (en) | Compositions and methods for treating or preventing ophthalmic light toxicity | |
ATE529415T1 (de) | Nitrosubstituierte phenylpiperazinverbindungen, deren herstellung und deren verwendung in medikamenten | |
WO2008157747A8 (en) | Use of inhibition of exonuclease 1 in methods for therapy and diagnostic of neurodegenerative diseases, eye diseases, and mitochondrial disorders | |
WO2007006521A3 (en) | Nutritional mixtures with a high and increased efficacy | |
ATE457779T1 (de) | Metallorganische komplexe auf manganbasis, pharmazeutische zusammensetzungen und diätetische produkte | |
ZA200700945B (en) | Derivatives of 1-phenylalkanecarboxylic acids for the treatment of neurodegenerative diseases | |
EP1958939A3 (de) | Pyrazolaminverbindungen zur Behandlung neurodegenerativer Erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |